You are here: Welcome » Virginia Benassi

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision
Previous revision
Both sides next revision
virginia_benassi [2022/09/14 00:34]
liam created
virginia_benassi [2022/09/14 00:40] (current)
liam [History]
Line 2: Line 2:
  
 **Virginia Benassi** is the Technical Officer for the [[World Health Organization]]'s R&D Blueprint.((//Request for Proposal (R4P) Evaluation of Supportive Care for Epidemics.// (2019, October 3). Wellcome Trust. https://web.archive.org/web/20220913223156/https://wellcome.org/sites/default/files/wellcome-rfp-2019-evaluation-supportive-care-epidemics.pdf)) **Virginia Benassi** is the Technical Officer for the [[World Health Organization]]'s R&D Blueprint.((//Request for Proposal (R4P) Evaluation of Supportive Care for Epidemics.// (2019, October 3). Wellcome Trust. https://web.archive.org/web/20220913223156/https://wellcome.org/sites/default/files/wellcome-rfp-2019-evaluation-supportive-care-epidemics.pdf))
 +
 +===== History =====
 +
 +In October 2019, Benassi was listed as a member of the Epidemics Supportive Care Guidelines (ESCG) panel for [[Wellcome Trust]] in a Request for Proposal document.((//Request for Proposal (R4P) Evaluation of Supportive Care for Epidemics.// (2019, October 3). Wellcome Trust. https://web.archive.org/web/20220913223156/https://wellcome.org/sites/default/files/wellcome-rfp-2019-evaluation-supportive-care-epidemics.pdf)) It stated the following:
 +
 +"We are seeking a supplier to evaluate the availability and quality of current supportive care guidelines (SCGs) for high-risk or epidemic-prone pathogens, examine SCG development and implementation, and assess the value of supportive care to R&D for medical countermeasures and the outcome of an outbreak/ epidemic."
Back to top